QQQ $ 481.74 $ 2.81 (0.59 %)
DIA $ 391.56 $ 0.33 (0.08 %)
SPY $ 545.33 $ 1.12 (0.21 %)
TLT $ 90.13 $ -1.58 (-1.73 %)
GLD $ 215.59 $ 0.56 (0.26 %)
$ 1.0E-6
-- x --
-- x --
-- - --
$ 0.00 - $ 0.02
2,000
na
na
$ 14.22
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 gelesis-maker-of-weight-loss-pill-concludes-spac-deal-trading-kickstarts-today

PureTech Health plc (NASDAQ: PRTC) founded entity Gelesis Inc, maker of weight management aid, has 

 48-biggest-movers-from-yesterday
48 Biggest Movers From Yesterday
01/12/2022 09:34:45

Gainers Splash Beverage Group, Inc. (NYSE: SBEV) shares jumped 70.6% to close at $1.80 on Tuesday after the company announce...

 30-stocks-moving-in-tuesdays-mid-day-session

Gainers TSR, Inc. (NASDAQ: TSRI) shares climbed 36.6% to $12.21 following Q2 results. The company reported Q2 revenue of $2...

 stocks-that-hit-52-week-lows-on-tuesday

  During Tuesday's morning trading, 87 companies set new 52-week lows.

 45-stocks-moving-in-mondays-mid-day-session

Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares climbed 71.5% to $5.88.

Core News & Articles

PureTech Health plc (NASDAQ:PRTC, LSE: PRTC)))) ("PureTech" or the "Company"), a clinical-stage biotherapeutics...

 capstar-special-purpose-acquisition-corp-reports-terms-of-deal-with-gelesis-revised-to-imply-equity-value-of-675m-down-from-900m

Capstar Special Purpose Acquisition Corp. (NYSE:CPSR) (“Capstar”), a special purpose acquisition company, announced that the va...

 capstar-special-purpose-acquisition-merging-partner-gelesis-announces-natures-scientific-reports-features-gelesis-novel-and-foundational-biomimetic-platform-for-treating-obesity-and-conditions-related-to-diet-induced-gut-damage

New paper describes the first superabsorbent hydrogel technology made from naturally derived building blocks designed to addres...

 fda-approved-weight-loss-drug-plenitys-parent-announces-spac-deal-what-investors-should-know

A SPAC deal announced Monday could help accelerate the manufacturing of a promising weight loss drug targeting over 150 million...

Core News & Articles

    During Thursday's morning session, 92 stocks hit new 52-week lows.

Core News & Articles

  Friday's session saw 466 companies set new 52-week highs.